Higher expression of CD11c, a marker expressed by DCs, macrophages, and monocytes, was associated with improved survival and was seen in ‘immune-excluded’ cf. ‘inflamed’ and ‘desert’ phenotypes as well as in stage III NPC. The gene discussed is ITGAX; the disease is nasopharyngeal carcinoma.